CORTELLI, PIETRO
 Distribuzione geografica
Continente #
AS - Asia 31.755
NA - Nord America 31.496
EU - Europa 22.550
SA - Sud America 1.839
AF - Africa 1.582
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 14
Totale 89.300
Nazione #
US - Stati Uniti d'America 31.087
VN - Vietnam 10.653
SG - Singapore 7.661
CN - Cina 7.122
IT - Italia 5.280
GB - Regno Unito 5.263
DE - Germania 3.053
HK - Hong Kong 2.206
SE - Svezia 1.835
FR - Francia 1.537
IN - India 1.366
BR - Brasile 1.314
RU - Federazione Russa 1.128
UA - Ucraina 1.059
IE - Irlanda 744
NL - Olanda 668
KR - Corea 661
JP - Giappone 501
ZA - Sudafrica 448
FI - Finlandia 413
CI - Costa d'Avorio 395
EE - Estonia 348
TG - Togo 285
CA - Canada 235
AT - Austria 223
SC - Seychelles 218
AR - Argentina 214
ID - Indonesia 176
JO - Giordania 171
PH - Filippine 169
CH - Svizzera 164
BD - Bangladesh 144
BG - Bulgaria 143
TH - Thailandia 124
MX - Messico 121
TR - Turchia 116
IQ - Iraq 115
BE - Belgio 111
ES - Italia 111
PL - Polonia 111
EC - Ecuador 92
GR - Grecia 84
TW - Taiwan 81
PK - Pakistan 80
UZ - Uzbekistan 77
NG - Nigeria 71
CO - Colombia 54
IR - Iran 53
AU - Australia 52
CL - Cile 51
HR - Croazia 44
SA - Arabia Saudita 43
LB - Libano 39
LT - Lituania 39
MY - Malesia 36
EG - Egitto 33
RO - Romania 33
VE - Venezuela 33
PY - Paraguay 30
TN - Tunisia 23
MA - Marocco 22
PE - Perù 22
CZ - Repubblica Ceca 21
ET - Etiopia 19
IL - Israele 19
KE - Kenya 17
HU - Ungheria 16
OM - Oman 16
PT - Portogallo 16
PS - Palestinian Territory 15
AZ - Azerbaigian 14
AL - Albania 13
KZ - Kazakistan 13
NO - Norvegia 13
NP - Nepal 13
UY - Uruguay 13
NZ - Nuova Zelanda 12
BO - Bolivia 11
DO - Repubblica Dominicana 11
RS - Serbia 11
DK - Danimarca 10
SK - Slovacchia (Repubblica Slovacca) 10
AE - Emirati Arabi Uniti 9
KG - Kirghizistan 9
LV - Lettonia 9
SI - Slovenia 9
SN - Senegal 9
BY - Bielorussia 8
CR - Costa Rica 8
DZ - Algeria 8
GE - Georgia 8
JM - Giamaica 8
HN - Honduras 7
SY - Repubblica araba siriana 7
BS - Bahamas 6
MD - Moldavia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
KH - Cambogia 5
QA - Qatar 5
Totale 89.199
Città #
Singapore 5.171
Southend 4.479
Ashburn 3.130
Fairfield 3.002
Ho Chi Minh City 2.574
Hanoi 2.287
Chandler 2.137
Hong Kong 2.065
San Jose 1.717
Ann Arbor 1.652
Woodbridge 1.497
Houston 1.442
Hefei 1.435
Seattle 1.341
Wilmington 1.333
Dong Ket 1.094
Princeton 1.065
Cambridge 1.047
Santa Clara 997
Bologna 979
Beijing 772
Dublin 738
Boardman 720
Jacksonville 631
Lauterbourg 604
Seoul 600
Los Angeles 526
Tokyo 438
Nanjing 427
Westminster 417
Abidjan 395
Padova 374
Milan 322
Helsinki 316
Berlin 313
Dallas 304
Da Nang 302
Turin 288
Buffalo 286
Haiphong 286
Lomé 285
Frankfurt am Main 266
New York 257
Council Bluffs 229
Jinan 215
Redmond 215
Rome 210
Saint Petersburg 205
Shenyang 195
Munich 188
San Diego 176
Amman 169
Changsha 164
Redondo Beach 161
Medford 159
Hebei 155
Bengaluru 144
Guangzhou 144
Sofia 140
Vienna 140
Biên Hòa 134
Hải Dương 132
Nanchang 132
Quận Bình Thạnh 131
São Paulo 131
Tianjin 131
Shanghai 128
Mülheim 127
Chicago 123
The Dalles 117
Florence 116
London 110
Des Moines 107
Brussels 104
Can Tho 101
Nuremberg 101
Jakarta 97
Zhengzhou 97
Bern 96
Amsterdam 95
Thái Nguyên 91
Dearborn 88
Toronto 88
Phoenix 82
Yubileyny 81
Verona 80
Vũng Tàu 80
Hangzhou 77
Jiaxing 75
Warsaw 75
Ha Long 73
Johannesburg 73
Ninh Bình 73
Atlanta 69
Moscow 69
Redwood City 69
Orem 66
Mahé 64
Bắc Giang 63
Quận Một 63
Totale 57.129
Nome #
Heritability of cluster headache 1.545
La sindrome della somatizzazione persistente secondo i Diagnostic Criteria for Psychosomatic Research: prevalenza e comorbilità psichiatriche e psicosomatiche nell’emicrania 689
Anterior callosal angle correlates with gait impairment and fall risk in iNPH patients 606
31P- and 1H-MR spectroscopy studies in familial hemiplegic migraine type 2 (FHM2). 353
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 353
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 341
The effects of cerebrospinal fluid tap-test on idiopathic normal pressure hydrocephalus: an inertial sensors based assessment 337
Skin biopsy and microneurography disclose selective noradrenergic dysfunction due to dopamine-β-hydroxylase deficiency 313
Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease 312
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease. 301
Circadian and state-dependent core body temperature in people with spinal cord injury 299
Monitoraggio clinico del Tilt Test: Task Force monitor e analisi HRV (Heart rate Variability) 296
Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment. 296
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 292
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 291
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project 290
Messenger RNA processing is altered in autosomal dominant leukodystrophy 278
Autonomic Dysfunctions in Sleep Disorders. 274
Autonomic innervation in multiple system atrophy and pure autonomic failure. 272
Evaluating gait and postural responses to subthalamic stimulation and levodopa: A prospective study using wearable technology 260
Analysis of Epigenetic Age Predictors in Pain-Related Conditions 256
L-dopa modulation of brain connectivity in Parkinson's disease patients: A pilot EEG-fmri study 253
Multi-class parkinsonian disorders classification with quantitative MR markers and graph-based features using support vector machines 253
Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment 251
Mice overexpressing lamin B1 in oligodendrocytes recapitulate the age-dependent motor signs, but not the early autonomic cardiovascular dysfunction of autosomal-dominant leukodystrophy (ADLD) 250
Supervised versus unsupervised technology-based levodopa monitoring in Parkinson’s disease: an intrasubject comparison 250
Allostatic load in migraine patients: a pilot study using an integrated psychosomatic and biochemical approach 246
Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation. 245
Precuneal Thickness and Depression in Parkinson Disease 245
A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. 244
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 240
A case of fatal familial insomnia in Africa. 237
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! 233
Abnormal in vivo cerebral energy metabolism in Huntington’s disease: preliminary findings 233
Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. 232
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy 230
Association between restless legs syndrome and migraine: a population-based study 230
Headache: clinical governance in health care management in the Emergency Department. 228
Clinical and neuroimaging evidence of interictal cerebellar dysfunction in FHM2. 223
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 223
Mathematical modeling and parameter estimation of levodopa motor response in patients with Parkinson disease 223
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 222
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy 222
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 221
Chronotypes in menstrual migraine: a case-control study. 220
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 220
Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy 219
Headache in epilepsy: prevalence and clinical features 219
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 219
Videopolygraphic and functional MRI study of musicogenic epilepsy. A case report and literature review. 218
Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy. 217
Pharmacogenetics of headache treatment 217
Binary and multi-class parkinsonian disorders classification using support vector machines 216
Wavelet analysis of the Valsalva maneuver: Methodology validation and application to pathological subjects 216
Detection of Brain-Derived Cell-Free DNA in Plasma 212
CLINIMETRIC ASSESSMENT OF PSYCHOLOGICAL AND PSYCHOSOCIAL FACTORS OF MIGRAINE: A PILOT STUDY 212
Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients. 211
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 209
Migraine chronification as an allostatic disorder: a proof-of-concept study 209
Autonomic nervous system laboratories: a European survey. 209
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? 209
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 208
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: Implications for pathophysiology. 206
Progression and prognosis in multiple system atrophy presenting with REM behavior disorder 205
Alterazione del metabolismo energetico cerebrale in vivo nella malattia di Huntington: dati preliminari 204
Cognitive function in peripheral autonomic disorders 203
Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease 203
A case of strictly unilateral migraine without aura transformed in an episodic hemicrania continua. 203
Association of Cardiovascular Autonomic Failure With Progression and Phenoconversion in Isolated REM Sleep Behavior Disorder 202
Stridor-related gray matter alterations in multiple system atrophy: A pilot study 202
Evidence-based diagnosis of nontraumatic headache in the emergency department: a consensus statement on four clinical scenarios. 201
Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases 201
Plasmapheresis improves the outcome of central pontine myelinolysis. 200
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients 198
Agrypnia Excitata 197
Corrigendum to “Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: Implications for pathophysiology” [Sleep Medicine 13/3 (2012) 252–262] 197
Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache 197
Physiological responses to pain in cancer patients: A systematic review 197
A Meta-Analysis of Brain DNA Methylation Across Sex, Age, and Alzheimer's Disease Points for Accelerated Epigenetic Aging in Neurodegeneration 197
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 197
The implantation and stimulation of posterior hypothalamus does not affect the circadian rhythm of core body temperature in chronic intractable cluster headache patients. 196
Discrepancies in reporting the CAG repeat lengths for Huntington's disease. 196
Absent cardiac and muscle sympathetic nerve activities involvement in Ross syndrome: A follow-up study 196
Chronic daily headache: risk factors and pathogenetic considerations. 196
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 196
Lack of association between five serotonin metabolism-related genes and medication overuse headache 195
Endozepines in recurrent stupor. 194
Neuropathological analisys and clinical correlates of chronic constipation in patients with parkinson’s disease 194
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 193
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 193
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study 192
Two year follow-up results of transcatheter closure of an interatrial cardiac defect in two migraine with aura (MWA) patients. 191
A BIOPSYCHOSOCIAL MODEL FOR CLINIMETRIC ASSESSMENT OF MIGRAINE: A PILOT STUDY 190
Neuroethological approach to frontolimbic epileptic seizures and parasomnias: the same central pattern generators for the same behaviours. 189
Increased prevalence of sleep disorders in chronic headache: a case-control study. 189
A mathematical model of levodopa medication effect on basal ganglia in parkinson’s disease: An application to the alternate finger tapping task 189
Homozygous PINK1 C-Terminus Mutation Causing Early-Onset Parkinsonism. 188
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 187
Neurological Manifestations of Long {COVID}: A Single-Center One-Year Experience 187
A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism 187
Totale 24.996
Categoria #
all - tutte 239.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.183 0 0 0 0 0 0 0 0 0 462 350 2.371
2021/20229.734 1.048 337 622 539 869 457 269 853 393 926 1.861 1.560
2022/20239.748 1.079 1.367 474 1.220 708 686 352 604 1.566 305 924 463
2023/20243.389 263 463 307 309 251 487 267 286 113 255 176 212
2024/202514.940 607 1.990 1.088 874 1.753 622 905 435 365 794 678 4.829
2025/202628.452 2.921 3.561 2.743 2.676 3.268 1.634 3.069 1.493 5.410 1.677 0 0
Totale 90.880